Idera Pharmaceuticals Inc. (IDRA: Quote) announced the U.S. FDA has granted orphan drug designation for IMO-8400, an antagonist of the endosomal Toll-like receptors (TLRs) 7, 8 and 9, for the treatment of Waldenström’s macroglobulinemia. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) in last trading activity moved up 1.03% to close at $4.41. Company weekly performance is 13.95% while its quarterly performance stands at 104.17%. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) is -35.81% away from its 52 week high.
On Dec 24, Freeport-McMoRan Inc. (NYSE:FCX) announced a successful production test from Freeport-McMoRan Oil & Gas’s (FM O&G) Highlander discovery, located onshore in South Louisiana in the Inboard Lower Tertiary/Cretaceous trend. On last trading day Freeport-McMoRan Inc. (NYSE:FCX) fell -0.93% to close at $23.36. Its volatility for the week is 2.55% while volatility for the month is 3.58%. FCX’s sales growth for past 5 years was 3.30% and its EPS growth for past 5 years was 16.80%. Freeport-McMoRan Inc. (NYSE:FCX) monthly performance is -10.84%.
On Dec. 19, The ExOne Company (NASDAQ:XONE), announced that it is implementing management changes effective immediately to provide direct and centralized operational control and reporting to its Chairman and Chief Executive Officer, S. Kent Rockwell.The ExOne Company (NASDAQ:XONE) has 12.70% insider ownership while its institutional ownership stands at 22.60%. In last trading activity company’s stock closed at $16.80.
Yandex NV (NASDAQ:YNDX) has received an average recommendation of “Buy” from the fourteen analysts that are presently covering the company, AnalystRatingsNetwork reports. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. On Wednesday shares of Yandex N.V. (NASDAQ:YNDX) closed at $17.96. Company’s sales growth for last 5 years was 38.90% and EPS growth for next 5 years is recorded as 14.70%.
S&W Seed Company (NASDAQ:SANW), announced the closing of the previously disclosed acquisition by S&W of DuPont Pioneer’s alfalfa production and research facility assets, as well as conventional (non-GMO) alfalfa germplasm, for a purchase price of up to $42 million. S&W Seed Company (NASDAQ:SANW) in last trading activity decreased -3.38% to close at $4.00. Company weekly performance is 0.00% while its quarterly performance stands at 6.67%. S&W Seed Company (NASDAQ:SANW) is -51.40% away from its 52 week high.